HEXO (HEXO) Stock Price, News & Analysis

Company Overview

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: C$0.88 to C$0.88
• 52-Week Range: N/A
• Volume: 72,643 shs
• Average Volume: 253,024 shs
• Market Capitalization: C$38.72 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HEXO Stock Analysis - Frequently Asked Questions

When did HEXO's stock split?

HEXO shares reverse split on Sunday, December 18th 2022. The 1-14 reverse split was announced on Sunday, December 18th 2022. The number of shares owned by shareholders was adjusted after the market closes on Sunday, December 18th 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

How do I buy shares of HEXO?

Shares of HEXO stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of HEXO own?

Based on aggregate information from My MarketBeat watchlists, some other companies that HEXO investors own include Aurora Cannabis (ACB), Aurora Cannabis (ACB), Meta Platforms (META), Tilray (TLRY), Canopy Growth (CGC), NVIDIA (NVDA) and Tesla (TSLA).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: TSE:HEXO
• CUSIP: N/A
• CIK: N/A
• Web: hexo.com
• Phone: 844-406-1852
• Fax: N/A
• Employees: 690
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($3.41)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: -0.18
• Net Income: C$-273,180,000.00
• Net Margins: -220.13%
• Pretax Margin: N/A
• Return on Equity: -106.39%
• Return on Assets: -14.96%

Debt

• Debt-to-Equity Ratio: 125.99
• Current Ratio: 0.41
• Quick Ratio: 0.40

Sales & Book Value

• Annual Sales: C$124.10 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 1.55
• Book Value: C$3.24 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 44,000,000
• Free Float: N/A
• Market Cap: C$38.72 million
• Optionable: Not Optionable
• Beta: 2.13